Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population

Clinical and Experimental Rheumatology

Volumn 16, Issue 1, 1998, Pages 9-13

  Kim, H A ^a   Yoo, C D ^a   Baek, H J ^a   Lee, E B ^a   Ahn, C ^a   Han, J S ^a   Kim, S ^a   Lee, J S ^a   Choe, K W ^a   Song, Y W ^a  

^a Seoul National University   (South Korea)

Author keywords

Corticosteroid; Incidence; Mycobacterium tuberculosis; Rheumatic disease; Risk factor

Indexed keywords

CORTICOSTEROID;

ARTICLE; CORTICOSTEROID THERAPY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; MYOSITIS; PREDNISOLONE; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 2642672794     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. SCHATZ M, PATERSON R, KLONER R, FALK J: The prevalence of tuberculosis and positive tuberculin tests in a steroid-treated asthmatic population. Ann Intern Med 1976; 84: 261-265.
2. LIEBERMAN P, PATTERSON R, KUNSKE R: Complications of long-term steroid treatment for asthma. J Allergy Clin Immunol 1972; 49: 329-36.
3. TAN EM, COHEN AS, FRIES JF: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-6.
4. BOHAN A, PETER JB: Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-347.
5. ALARCON-SEGOVIA D, CARDIEL MH: Comparison between three diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989; 16: 328-34.
6. COMMITTEE ON PROGNOSIS STUDIES IN SLE: Prognosis studies in SLE: An activity index. Arthritis Rheum 1986; 29 (Suppl.): S93.
7. KIM SJ, HONG YP, LEW WJ, YANG SC, LEE EG: Incidence of pulmonary tuberculosis in Korean civil servants. Tubercle and Lung Disease 1995; 76: 534-9.
8. KOREAN NATIONAL TUBERCULOSIS ASSOCIATION (Eds.): Report on the 7th Tuberculosis Prevalence Survey in Korea, Seoul, Ministry of Health and Social Affairs, 1995; 15-36.
9. ORME IM, ANDERSEN P, BOOM WH: T cell response to mycobacterium tuberculosis. J Infect Dis 1993; 167: 1481-97.
10. BALOW JE, ROSENTHAL AS: Glucocorticoid suppression of macrophage migration inhibitory factor. J Exp Med 1973; 137: 1031-1041.
11. RINEHART JJ, SAGONE AL, BALCERZAK SP, ACKERMAN GA, LOBUGLIO AF: Effects of corticosteroid therapy on human monocyte function. N Eng J Med 1975; 292: 236-41.
12. RICCARD PJ, HAUSMAN PB, RAFF HV: The autologous mixed lymphocyte reaction in systemic lupus erythematosus. Arthritis Rheum 1982; 25: 820-3.
13. KIM JH, LANGSTON AA, GALLIS HA: Miliary tuberculosis: Epidemiology, clinical manifestations, diagnosis, and outcome. Rev Infect Dis 1990; 12: 583-90.
14. SMALL PM, SHAFER RW, HOPEWELL DC: Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993; 328: 1137-44.
15. CENTERS FOR DISEASE CONTROL AND PREVENTION: The use of preventive therapy for tuberculous infection in the United States: Recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR 1990; 39 (RR-8): 9-12.
16. SMYLLIE HC, CONNOLLY CK: Incidence of serious complications of corticosteroid therapy in respiratory disease. Thorax 1968; 23: 571-81.